Document Page: First | Prev | Next | All | Image | This Release | Search

File: 102596_sep96_decls2_0027.txt
Page: 0027
Total Pages: 28

Subject: DIARRHEAL DISEASES                                              

Unit: VAR. BUMED  

Parent Organization: BUMED       

Box ID: BX303811

Folder Title: VARIOUS NAVAL MESSAGES FOLDER 1                                                                 

Document Number:         16

Folder SEQ  #:          2







                             Hepatitis B with active viral replication and
                             greater infectiousness.
                      e. knti-Hepatitis B surface antibody appears during
                             convalescence-it indicates prior infection, and
                             is not useful for directly diagnosing active
                             hepatitis.
                      f.   IgM anti-Hepatitis B core antibody indicates
                             acute infection with Hepatitis B.
                      9.     Anti-Hepatitis C antibody indicates prior
                             infection with Hepatitis C. It is not useful
                             for directly diagnosing active hepatitis.

                  6. Coagulation:
                       a. generally normal in uncomplicated acute viral
                       hepatitis.
                       b.    Prothrombin time (PT) rises in fulminant
                       hepatitis.

             D. X-ray: non specific.

             E. Invasive Procedures: not indicated

             F. Diagnostic Confirmation: serologic.

       IV. Duration:
            A. icteric phase: 1-3 weeks.
            B. Convalescent phase: may require up to several months.

       V. Complications:
           A. Fulminant Hepatitis:
                 1. Presentation: hepatic encephalopathy, asterixis, coma,
                    coagulopathy, death.
               2. Treatment:
                    a. Supportive to include bed rest, protein
                        restriction.
                    b. Lactulose in sorbitol orally, if tolerated;
                        by enema otherwise, or oral neomycin.

           B. Progression to Chronic Hepatitis: occurs rarely if ever
                  in Hepatitis A, in 5-10% of Hepatitis B, and in up to
                  50-70% of Hepatitis C.

           C. Pancreatitis:


       VI. Treatment:
            No specific treatment is available for viral hepatitis. Rest
inue any nonessential medications.

       VII. Disposition:
             A. Mild cases may be hospitalized in theater as some will
                  be able to return to duty in 2-3 weeks.
             B. Evacuate moderate or severe cases.

Document Page: First | Prev | Next | All | Image | This Release | Search


Document 28 f:/Week-37/BX303811/VARIOUS NAVAL MESSAGES FOLDER 1/diarrheal diseases:1018961450003
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-37
Box ID = BX303811
Unit = VAR. BUMED
Parent Organization = BUMED
Folder Title = VARIOUS NAVAL MESSAGES FOLDER 1
Folder Seq # = 2
Subject = DIARRHEAL DISEASES
Document Seq # = 16
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 18-OCT-1996